NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk inkl
NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk Medical Daily
NIH funds study of forever chemicals’ liver and endometrial cancer risks Bioengineer.org
Weight-loss drugs linked to lower cancer risk in obese people without diabetes Nature
Drinking Water Contaminants Tied to Uterine Cancer Risk Medscape
Assisted reproductive technology (ART) is increasingly utilized worldwide, yet concerns remain regarding its potential association with breast and gynecological malignancies and the safety of fertility-preservation strategies in cancer survivors. Ovarian …
Background/Objectives: The levonorgestrel-releasing intrauterine device (LNG-IUD) is widely used as a long-acting reversible contraceptive and as a therapeutic option for heavy menstrual bleeding, endometriosis, adenomyosis, and endometrial hyperplasia. Although its …
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Escuela Andaluza de Salud Pública
Non-hormonal intrauterine devices (IUDs) create an inflammatory uterine environment while oral contraceptives (OC) suppress ovulation and have different associations with ovarian cancer risk. We have evaluated the associations of these …
Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …